Our study aimed to explore the correlation between serum adiponectin concentrations and liver dysfunction, investigating adiponectin as a potential biomarker in critically ill patients with decompensated advanced chronic liver disease, acute-on-chronic liver failure, and acute liver failure. This evidence concerns the gene ADIPOQ and acute liver failure.